HYEWON AN: Open Payments
NPI 1407243843 · WOODSIDE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 15 payments from 8 companies in 2025. Trend: 2023 $646 · 2024 $413 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: EVENITY, FARXIGA, MOUNJARO, OTEZLA, JARDIANCE, PAXLOVID, TRELEGY ELLIPTA, Tirosint.
Industry payments across NY — which companies pay providers there.
